Vimta Labs Limited has informed the Exchange regarding a press release dated January 28, 2026, titled "Q3 FY 2025-26- Press Release for the 3rd Quarter and Nine Months ended 31st Dec 2025".
VIMTALABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.8 pts less than Nifty Microcap 250 and 6.8 pts less than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vimta Labs has informed the stock exchange about a press release dated January 28, 2026, covering its financial performance for the third quarter and nine months ended December 31, 2025. This is a routine intimation filing that simply notifies the exchange that a press release has been issued. The actual quarterly numbers, commentary, and any management guidance would be contained in the press release itself, which is not included in this filing. Investors need to refer to the press release or the separately filed financial results for detailed performance data.
No direct impact on shareholders from this intimation alone, as it does not contain financial figures or forward-looking guidance. Investors should look at the accompanying press release and Q3 results filing for actual numbers and outlook before making any decisions.